These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression. Pfeffer CR Am J Psychiatry; 2007 Jun; 164(6):843-6. PubMed ID: 17541037 [No Abstract] [Full Text] [Related]
4. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Olfson M; Marcus SC; Shaffer D Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062 [TBL] [Abstract][Full Text] [Related]
5. FDA questions antidepressant safety for children. Oransky I Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000 [No Abstract] [Full Text] [Related]
6. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123 [TBL] [Abstract][Full Text] [Related]
7. How can we know whether antidepressants increase suicide risk? Simon GE Am J Psychiatry; 2006 Nov; 163(11):1861-3. PubMed ID: 17074930 [No Abstract] [Full Text] [Related]
8. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Posner K; Oquendo MA; Gould M; Stanley B; Davies M Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655 [TBL] [Abstract][Full Text] [Related]
10. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Leon AC Am J Psychiatry; 2007 Dec; 164(12):1786-9. PubMed ID: 18056231 [No Abstract] [Full Text] [Related]
11. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. Gupta S; Gersing KR; Erkanli A; Burt T Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613 [TBL] [Abstract][Full Text] [Related]
12. The current crisis of confidence in antidepressants. Nierenberg AA; Leon A; Price LH; Shelton RC; Trivedi MH J Clin Psychiatry; 2011 Jan; 72(1):27-33. PubMed ID: 21272514 [No Abstract] [Full Text] [Related]
13. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. Stone M; Laughren T; Jones ML; Levenson M; Holland PC; Hughes A; Hammad TA; Temple R; Rochester G BMJ; 2009 Aug; 339():b2880. PubMed ID: 19671933 [TBL] [Abstract][Full Text] [Related]
14. Suicide risk during antidepressant treatment. Simon GE; Savarino J; Operskalski B; Wang PS Am J Psychiatry; 2006 Jan; 163(1):41-7. PubMed ID: 16390887 [TBL] [Abstract][Full Text] [Related]
17. SSRI prescriptions and the rate of suicide. Olfson M; Shaffer D Am J Psychiatry; 2007 Dec; 164(12):1907-8; author reply 1908-10. PubMed ID: 18056247 [No Abstract] [Full Text] [Related]
18. Suicidal risk in antidepressant drug trials. Baldessarini RJ; Pompili M; Tondo L Arch Gen Psychiatry; 2006 Mar; 63(3):246-8. PubMed ID: 16520428 [No Abstract] [Full Text] [Related]
19. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141 [TBL] [Abstract][Full Text] [Related]
20. The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. Leslie LK; Newman TB; Chesney PJ; Perrin JM Pediatrics; 2005 Jul; 116(1):195-204. PubMed ID: 15995053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]